Does the 15q13.3 microduplication protect against epilepsy?

The publication of recent papers by Mefford et al. [1] and Cooper et al. [2] brought up an interesting issue again concerning the role of the 15q13.3 microduplication.  While the 15q13.3 microdeletion is a well-established risk factor for epilepsy, particularly, idiopathic generalised (genetic generalised epilepsy), the role of the reciprocal microduplication is not clear. In two epilepsy cohorts this microduplication is absent in 1223 IGE patients [3], 517 epilepsy patients [4] and 315 patients with epileptic encephalopathies [1].

This variant is seen in two control cohorts at a frequency of 0.5% (2/3699, 3/8329) [2, 3] and in a mixed cohort of patients with intellectual disability at 0.13% (20/15,767) [2], the absence in IGE and other pure epilepsy cohorts is intriguing (Table 1).

Table 1
15q13.3 dup n %
Intellectual disability 20 15,767 0.13
controls 25 27,795 0.09
IGE/GGE, epilepsy 0 2055 0.00

Neither comparison between two groups using a Fisher’s exact test is significant, given that it is conceptually difficult to arrive at statistical significant results with very small frequencies.  However, comparing these three frequencies using a Chi square test, the differences are significant at p=0.02. Accordingly, this might indicate that the 15q13.3 microduplication is a protective factor against epilepsy or the differences are due to ascertainment bias.

Ingo

1. Mefford, H., Rare copy number variants are an important cause of epileptic encephalopathies. 2011.

2. Cooper, G.M., et al., A copy number variation morbidity map of developmental delay. Nat Genet, 2011. 43(9): p. 838-46.

3. Helbig, I., et al., 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet, 2009. 41(2): p. 160-2.

4. Mefford, H.C., et al., Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet, 2010. 6(5): p. e1000962.

Please quote this blog (APA format) as

Helbig, I. Does the 15q13.3 microduplication protect against epilepsy?. Retrieved [enter date], from http://www.euroepinomics.wordpress.com

8 thoughts on “Does the 15q13.3 microduplication protect against epilepsy?

  1. Pingback: One fish, two fish, red fish, blue fish – KCTD13 and neurogenetic studies in zebrafish | EuroEPINOMICS

  2. Pingback: How human evolution has shaped epilepsy genes | EuroEPINOMICS

  3. Pingback: Copy numbers, seizures and speech | EuroEPINOMICS

  4. Pingback: Mutations don’t always cause disease, quite the opposite | EuroEPINOMICS

  5. Pingback: Close encounters of the third kind – rare genetic variants in families | Beyond the Ion Channel

  6. Pingback: The 16p11.2 microdeletion: assessing the phenotypic range | Beyond the Ion Channel

  7. Pingback: “Meta-channelopathies” – RBFOX1 deletions and human epilepsy | Beyond the Ion Channel

  8. Pingback: Identifying core phenotypes – epilepsy, ID and recurrent microdeletions | Beyond the Ion Channel

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s